1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Papilloma Virus (HPV) Screening Kits Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Human Papilloma Virus (HPV) Screening Kits by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Human Papilloma Virus (HPV) Screening Kits by Country/Region, 2018, 2022 & 2029
2.2 Human Papilloma Virus (HPV) Screening Kits Segment by Detected Number of HPV Types
2.2.1 15 Below
2.2.2 15-20
2.2.3 20 Above
2.3 Human Papilloma Virus (HPV) Screening Kits Sales by Detected Number of HPV Types
2.3.1 Global Human Papilloma Virus (HPV) Screening Kits Sales Market Share by Detected Number of HPV Types (2018-2023)
2.3.2 Global Human Papilloma Virus (HPV) Screening Kits Revenue and Market Share by Detected Number of HPV Types (2018-2023)
2.3.3 Global Human Papilloma Virus (HPV) Screening Kits Sale Price by Detected Number of HPV Types (2018-2023)
2.4 Human Papilloma Virus (HPV) Screening Kits Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Third-party Testing Agency
2.4.4 Others
2.5 Human Papilloma Virus (HPV) Screening Kits Sales by Application
2.5.1 Global Human Papilloma Virus (HPV) Screening Kits Sale Market Share by Application (2018-2023)
2.5.2 Global Human Papilloma Virus (HPV) Screening Kits Revenue and Market Share by Application (2018-2023)
2.5.3 Global Human Papilloma Virus (HPV) Screening Kits Sale Price by Application (2018-2023)
3 Global Human Papilloma Virus (HPV) Screening Kits by Company
3.1 Global Human Papilloma Virus (HPV) Screening Kits Breakdown Data by Company
3.1.1 Global Human Papilloma Virus (HPV) Screening Kits Annual Sales by Company (2018-2023)
3.1.2 Global Human Papilloma Virus (HPV) Screening Kits Sales Market Share by Company (2018-2023)
3.2 Global Human Papilloma Virus (HPV) Screening Kits Annual Revenue by Company (2018-2023)
3.2.1 Global Human Papilloma Virus (HPV) Screening Kits Revenue by Company (2018-2023)
3.2.2 Global Human Papilloma Virus (HPV) Screening Kits Revenue Market Share by Company (2018-2023)
3.3 Global Human Papilloma Virus (HPV) Screening Kits Sale Price by Company
3.4 Key Manufacturers Human Papilloma Virus (HPV) Screening Kits Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Papilloma Virus (HPV) Screening Kits Product Location Distribution
3.4.2 Players Human Papilloma Virus (HPV) Screening Kits Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Papilloma Virus (HPV) Screening Kits by Geographic Region
4.1 World Historic Human Papilloma Virus (HPV) Screening Kits Market Size by Geographic Region (2018-2023)
4.1.1 Global Human Papilloma Virus (HPV) Screening Kits Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Human Papilloma Virus (HPV) Screening Kits Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Human Papilloma Virus (HPV) Screening Kits Market Size by Country/Region (2018-2023)
4.2.1 Global Human Papilloma Virus (HPV) Screening Kits Annual Sales by Country/Region (2018-2023)
4.2.2 Global Human Papilloma Virus (HPV) Screening Kits Annual Revenue by Country/Region (2018-2023)
4.3 Americas Human Papilloma Virus (HPV) Screening Kits Sales Growth
4.4 APAC Human Papilloma Virus (HPV) Screening Kits Sales Growth
4.5 Europe Human Papilloma Virus (HPV) Screening Kits Sales Growth
4.6 Middle East & Africa Human Papilloma Virus (HPV) Screening Kits Sales Growth
5 Americas
5.1 Americas Human Papilloma Virus (HPV) Screening Kits Sales by Country
5.1.1 Americas Human Papilloma Virus (HPV) Screening Kits Sales by Country (2018-2023)
5.1.2 Americas Human Papilloma Virus (HPV) Screening Kits Revenue by Country (2018-2023)
5.2 Americas Human Papilloma Virus (HPV) Screening Kits Sales by Detected Number of HPV Types
5.3 Americas Human Papilloma Virus (HPV) Screening Kits Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Papilloma Virus (HPV) Screening Kits Sales by Region
6.1.1 APAC Human Papilloma Virus (HPV) Screening Kits Sales by Region (2018-2023)
6.1.2 APAC Human Papilloma Virus (HPV) Screening Kits Revenue by Region (2018-2023)
6.2 APAC Human Papilloma Virus (HPV) Screening Kits Sales by Detected Number of HPV Types
6.3 APAC Human Papilloma Virus (HPV) Screening Kits Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Papilloma Virus (HPV) Screening Kits by Country
7.1.1 Europe Human Papilloma Virus (HPV) Screening Kits Sales by Country (2018-2023)
7.1.2 Europe Human Papilloma Virus (HPV) Screening Kits Revenue by Country (2018-2023)
7.2 Europe Human Papilloma Virus (HPV) Screening Kits Sales by Detected Number of HPV Types
7.3 Europe Human Papilloma Virus (HPV) Screening Kits Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Papilloma Virus (HPV) Screening Kits by Country
8.1.1 Middle East & Africa Human Papilloma Virus (HPV) Screening Kits Sales by Country (2018-2023)
8.1.2 Middle East & Africa Human Papilloma Virus (HPV) Screening Kits Revenue by Country (2018-2023)
8.2 Middle East & Africa Human Papilloma Virus (HPV) Screening Kits Sales by Detected Number of HPV Types
8.3 Middle East & Africa Human Papilloma Virus (HPV) Screening Kits Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Papilloma Virus (HPV) Screening Kits
10.3 Manufacturing Process Analysis of Human Papilloma Virus (HPV) Screening Kits
10.4 Industry Chain Structure of Human Papilloma Virus (HPV) Screening Kits
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Papilloma Virus (HPV) Screening Kits Distributors
11.3 Human Papilloma Virus (HPV) Screening Kits Customer
12 World Forecast Review for Human Papilloma Virus (HPV) Screening Kits by Geographic Region
12.1 Global Human Papilloma Virus (HPV) Screening Kits Market Size Forecast by Region
12.1.1 Global Human Papilloma Virus (HPV) Screening Kits Forecast by Region (2024-2029)
12.1.2 Global Human Papilloma Virus (HPV) Screening Kits Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Papilloma Virus (HPV) Screening Kits Forecast by Detected Number of HPV Types
12.7 Global Human Papilloma Virus (HPV) Screening Kits Forecast by Application
13 Key Players Analysis
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Information
13.1.2 Roche Diagnostics Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.1.3 Roche Diagnostics Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Diagnostics Main Business Overview
13.1.5 Roche Diagnostics Latest Developments
13.2 QIAGEN
13.2.1 QIAGEN Company Information
13.2.2 QIAGEN Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.2.3 QIAGEN Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 QIAGEN Main Business Overview
13.2.5 QIAGEN Latest Developments
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Information
13.3.2 Thermo Fisher Scientific Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.3.3 Thermo Fisher Scientific Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Thermo Fisher Scientific Main Business Overview
13.3.5 Thermo Fisher Scientific Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.4.3 Abbott Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 BD
13.5.1 BD Company Information
13.5.2 BD Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.5.3 BD Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 BD Main Business Overview
13.5.5 BD Latest Developments
13.6 Hologic
13.6.1 Hologic Company Information
13.6.2 Hologic Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.6.3 Hologic Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hologic Main Business Overview
13.6.5 Hologic Latest Developments
13.7 Cepheid
13.7.1 Cepheid Company Information
13.7.2 Cepheid Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.7.3 Cepheid Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cepheid Main Business Overview
13.7.5 Cepheid Latest Developments
13.8 Bio-rad
13.8.1 Bio-rad Company Information
13.8.2 Bio-rad Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.8.3 Bio-rad Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bio-rad Main Business Overview
13.8.5 Bio-rad Latest Developments
13.9 Seegene
13.9.1 Seegene Company Information
13.9.2 Seegene Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.9.3 Seegene Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Seegene Main Business Overview
13.9.5 Seegene Latest Developments
13.10 bioMérieux
13.10.1 bioMérieux Company Information
13.10.2 bioMérieux Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.10.3 bioMérieux Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 bioMérieux Main Business Overview
13.10.5 bioMérieux Latest Developments
13.11 Hybribio
13.11.1 Hybribio Company Information
13.11.2 Hybribio Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.11.3 Hybribio Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hybribio Main Business Overview
13.11.5 Hybribio Latest Developments
13.12 Daan Gene
13.12.1 Daan Gene Company Information
13.12.2 Daan Gene Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.12.3 Daan Gene Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Daan Gene Main Business Overview
13.12.5 Daan Gene Latest Developments
13.13 BGI Group
13.13.1 BGI Group Company Information
13.13.2 BGI Group Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.13.3 BGI Group Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 BGI Group Main Business Overview
13.13.5 BGI Group Latest Developments
13.14 Shanghai ZJ Bio-tech
13.14.1 Shanghai ZJ Bio-tech Company Information
13.14.2 Shanghai ZJ Bio-tech Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.14.3 Shanghai ZJ Bio-tech Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Shanghai ZJ Bio-tech Main Business Overview
13.14.5 Shanghai ZJ Bio-tech Latest Developments
13.15 Taipu Bioscience
13.15.1 Taipu Bioscience Company Information
13.15.2 Taipu Bioscience Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.15.3 Taipu Bioscience Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Taipu Bioscience Main Business Overview
13.15.5 Taipu Bioscience Latest Developments
13.16 Tellgen Corporation
13.16.1 Tellgen Corporation Company Information
13.16.2 Tellgen Corporation Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.16.3 Tellgen Corporation Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Tellgen Corporation Main Business Overview
13.16.5 Tellgen Corporation Latest Developments
13.17 Orient Gene Biotech
13.17.1 Orient Gene Biotech Company Information
13.17.2 Orient Gene Biotech Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.17.3 Orient Gene Biotech Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Orient Gene Biotech Main Business Overview
13.17.5 Orient Gene Biotech Latest Developments
13.18 Shenzhen Yaneng Biological Technology
13.18.1 Shenzhen Yaneng Biological Technology Company Information
13.18.2 Shenzhen Yaneng Biological Technology Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.18.3 Shenzhen Yaneng Biological Technology Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Shenzhen Yaneng Biological Technology Main Business Overview
13.18.5 Shenzhen Yaneng Biological Technology Latest Developments
13.19 Jiangsu Bioperfectus Technologies
13.19.1 Jiangsu Bioperfectus Technologies Company Information
13.19.2 Jiangsu Bioperfectus Technologies Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.19.3 Jiangsu Bioperfectus Technologies Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Jiangsu Bioperfectus Technologies Main Business Overview
13.19.5 Jiangsu Bioperfectus Technologies Latest Developments
13.20 Xiamen Zhishan Biological Technology
13.20.1 Xiamen Zhishan Biological Technology Company Information
13.20.2 Xiamen Zhishan Biological Technology Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.20.3 Xiamen Zhishan Biological Technology Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Xiamen Zhishan Biological Technology Main Business Overview
13.20.5 Xiamen Zhishan Biological Technology Latest Developments
13.21 ACON Laboratories
13.21.1 ACON Laboratories Company Information
13.21.2 ACON Laboratories Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.21.3 ACON Laboratories Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 ACON Laboratories Main Business Overview
13.21.5 ACON Laboratories Latest Developments
13.22 National Bio-founder Biotech
13.22.1 National Bio-founder Biotech Company Information
13.22.2 National Bio-founder Biotech Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.22.3 National Bio-founder Biotech Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 National Bio-founder Biotech Main Business Overview
13.22.5 National Bio-founder Biotech Latest Developments
13.23 Sansure Biotech
13.23.1 Sansure Biotech Company Information
13.23.2 Sansure Biotech Human Papilloma Virus (HPV) Screening Kits Product Portfolios and Specifications
13.23.3 Sansure Biotech Human Papilloma Virus (HPV) Screening Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Sansure Biotech Main Business Overview
13.23.5 Sansure Biotech Latest Developments
14 Research Findings and Conclusion
※参考情報 ヒトパピローマウイルス(HPV)スクリーニングキットは、ヒトパピローマウイルスに関連する感染の有無を検査するための道具です。HPVは、性行為を通じて感染するウイルスであり、数十種類のタイプが存在します。その中には、子宮頸癌をはじめとするさまざまな癌の発症に深く関与するタイプもあります。HPVスクリーニングキットは、これらのウイルスの感染を早期に発見し、適切な対応を行うために重要な役割を果たします。 HPVスクリーニングキットの主な特徴の一つは、簡便性です。多くのキットは自宅で使用可能であり、個人がプライバシーを保ちながら検査を行うことができます。一般的な手順としては、サンプルを採取し、付属の容器に入れて郵送する形が多いです。検査結果は後日、指定された方法で通知されます。この手軽さにより、検査を受けることに対するハードルが下がり、早期発見につながる可能性が高まります。 スクリーニングキットには主に2つのタイプがあります。第一のタイプは、HPV感染の有無を直接検出するものです。これは、ウイルスのDNAまたはRNAを特定し、感染部位にウイルスが存在するかどうかを判断します。特に高リスク型HPVを特定することで、癌のリスクを評価できる点が重要です。第二のタイプは、細胞検査と組み合わせて行うもので、子宮頸部の細胞を採取し、異常がないかを確認します。これにより、HPV感染によって引き起こされる細胞の変化を評価できます。 HPVスクリーニングキットの用途は広範で、主に女性の健康管理において重要視されています。特に、子宮頸癌の予防や早期発見に寄与します。日本では、20歳を過ぎた女性に対してHPV検査が推奨されており、定期的なスクリーニングによって癌のリスクを大幅に低下させることができます。また、男性においても、HPVに関連するがんのリスクを把握するための検査の需要が高まっています。 関連技術としては、分子生物学的技術が挙げられます。特にPCR(ポリメラーゼ連鎖反応)技術は、HPVのDNA検出に広く利用されています。この技術は、微量のDNAを効率的に増幅できるため、高感度での検出が可能です。また、次世代シーケンシング技術を用いることで、HPVのさまざまな型を同時に検出できる手法も開発されており、より多様な解析が可能となっています。 HPVスクリーニングキットの利用には注意点もあります。検査結果の解釈には専門的な知識が必要であり、陽性と判定された場合、必ず医療機関での再検査やフォローアップが求められます。また、スクリーニングはあくまで感染の有無を確認するものであり、直ちに治療を意味するものではありません。感染が確認された場合は、専門医による適切なアドバイスを受けることが重要です。 近年では、HPVワクチンの普及も進んでおり、スクリーニングキットとの相乗効果が期待されています。ワクチン接種によりHPVの感染リスクを減少させる一方で、定期的なスクリーニングによって、万が一感染している場合でも早期に発見し、治療につなげることが可能となります。このように、HPVスクリーニングキットは、女性の健康管理においてなくてはならないツールとなっています。 まとめると、ヒトパピローマウイルススクリーニングキットは、HPV感染の早期発見を可能にする重要なツールです。その簡便性、正確性、そして早期発見につながる点から、多くの人々にとって重要な健康管理の一環として位置づけられています。今後も新しい技術の開発や教育が進むことで、さらに多くの人々がHPV検査を受けやすくなり、結果として子宮頸癌などの予防につながることが期待されています。これらの取り組みを通じて、HPVに関連する健康問題を減少させ、より多くの人々の健康を守ることができるでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/